Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.
2.
3.

Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.

Wodarz D, Nowak MA.

Philos Trans R Soc Lond B Biol Sci. 2000 Aug 29;355(1400):1059-70. Review.

4.

What do mathematical models tell us about killing rates during HIV-1 infection?

Gadhamsetty S, Beltman JB, de Boer RJ.

Immunol Lett. 2015 Nov;168(1):1-6. doi: 10.1016/j.imlet.2015.07.009. Epub 2015 Aug 13. Review.

5.

Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowitz M, Ho DD, Nixon DF, McMichael AJ.

Science. 1998 Mar 27;279(5359):2103-6.

7.

Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells.

Kottilil S, Gamberg J, Bowmer I, Trahey J, Howley C, Gallant M, Grant M.

J Clin Immunol. 2000 May;20(3):175-86.

PMID:
10941825
8.
9.

Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity.

Joseph A, Zheng JH, Follenzi A, Dilorenzo T, Sango K, Hyman J, Chen K, Piechocka-Trocha A, Brander C, Hooijberg E, Vignali DA, Walker BD, Goldstein H.

J Virol. 2008 Mar;82(6):3078-89. doi: 10.1128/JVI.01812-07. Epub 2008 Jan 9.

10.

Two types of cytotoxic lymphocyte regulation explain kinetics of immune response to human immunodeficiency virus.

Rouzine IM, Sergeev RA, Glushtsov AI.

Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):666-71. Epub 2006 Jan 5.

11.

A condition for successful escape of a mutant after primary HIV infection.

Monteiro LH, Gonçalves CH, Piqueira JR.

J Theor Biol. 2000 Apr 21;203(4):399-406.

PMID:
10736216
12.

Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL.

Yang OO, Sarkis PT, Trocha A, Kalams SA, Johnson RP, Walker BD.

J Immunol. 2003 Oct 1;171(7):3718-24.

13.
14.

Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.

Yokomaku Y, Miura H, Tomiyama H, Kawana-Tachikawa A, Takiguchi M, Kojima A, Nagai Y, Iwamoto A, Matsuda Z, Ariyoshi K.

J Virol. 2004 Feb;78(3):1324-32.

15.

Modeling plasma virus concentration during primary HIV infection.

Stafford MA, Corey L, Cao Y, Daar ES, Ho DD, Perelson AS.

J Theor Biol. 2000 Apr 7;203(3):285-301.

PMID:
10716909
16.
17.

Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo.

Asquith B, Edwards CT, Lipsitch M, McLean AR.

PLoS Biol. 2006 Apr;4(4):e90. Epub 2006 Mar 14.

18.

Virus-specific cytotoxic T lymphocyte responses in patients infected with the human immunodeficiency virus, HIV-1.

Rivière Y.

Cell Mol Biol (Noisy-le-grand). 1994;40 Suppl 1:45-8. Review.

PMID:
7950861
20.

Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection.

Klenerman P, Phillips RE, Rinaldo CR, Wahl LM, Ogg G, May RM, McMichael AJ, Nowak MA.

Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15323-8.

Items per page

Supplemental Content

Write to the Help Desk